Technical Analysis for ACW - Actinogen Medical Ltd  

Grade Last Price % Change Price Change
grade F 0.023 -4.17% -0.001
ACW closed down 4.17 percent on Thursday, August 13, 2020, on 14 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical ACW trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Doji - Bullish? Reversal 0.00%
Fell Below 50 DMA Bearish -4.17%
180 Bearish Setup Bearish Swing Setup -4.17%
Crossed Above 20 DMA Bullish -8.00%
Crossed Above 50 DMA Bullish -8.00%
180 Bullish Setup Bullish Swing Setup -8.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -8.00%
Fell Below 20 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Interactive chart

Profile

Actinogen Medical Limited, formerly Actinogen Limited, is a clinical-stage biotechnology company. The Company focuses on the treatment of Alzheimer's disease and age-related neurodegenerative diseases. The Company is engaged in treating cognitive impairment in chronic neurodegenerative diseases through the inhibition of cortisol production. The Company's Xanamem is a drug under development for the treatment of Alzheimer's disease, which is designed to block the production of cortisol in the brain. Xanamem's mechanism of action is to block the activity of a specific enzyme in the brain, the 11B-HSD1 enzyme. It focuses on Xanamem in the clinical areas, including Diabetes-Cognitive dysfunction, Cognitive dysfunction in Parkinson's Disease, Post Traumatic Stress Disorder (PTSD), Cognitive dysfunction in schizophrenia and depression, and Cardiovascular disease-Post myocardial infarction. It focuses on Phase II XanADu efficacy and safety study with mild Alzheimer's disease patients.
Medicine Biotechnology RTT Psychiatric Diagnosis Psychiatry Dementia Alzheimer's Disease Parkinson's Disease Depression Treatment Of Alzheimer's Disease

Is ACW a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.066
52 Week Low 0.007
Average Volume 4,903,626
200-Day Moving Average 0.028
50-Day Moving Average 0.024
20-Day Moving Average 0.024
10-Day Moving Average 0.024
Average True Range 0.002
ADX 23.15
+DI 24.082
-DI 22.449
Chandelier Exit (Long, 3 ATRs ) 0.023
Chandelier Exit (Short, 3 ATRs ) 0.026
Upper Bollinger Band 0.026
Lower Bollinger Band 0.021
Percent B (%b) 0.39
BandWidth 22.881
MACD Line 0.000
MACD Signal Line 0.000
MACD Histogram 0.0001
Fundamentals Value
Market Cap 14.26 Million
Num Shares 620 Million
EPS -0.01
Price-to-Earnings (P/E) Ratio -4.60
Price-to-Sales 24.97
Price-to-Book 3.80
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.025
Resistance 3 (R3) 0.025 0.024 0.024
Resistance 2 (R2) 0.024 0.024 0.024 0.024
Resistance 1 (R1) 0.024 0.024 0.024 0.024 0.024
Pivot Point 0.023 0.023 0.023 0.023 0.023
Support 1 (S1) 0.023 0.023 0.023 0.023 0.022
Support 2 (S2) 0.022 0.023 0.022 0.022
Support 3 (S3) 0.022 0.022 0.022
Support 4 (S4) 0.022